OnKure Therapeutics, Inc.

NASDAQ:OKUR

Biotechnology

Healthcare
$2.76 +0.23%

+$0.01 today

Market cap
$111.79M
Beta
0.28
P/E (TTM)
-1.0
EPS (TTM)
-$4.30
52W Low $1.91High $5.38

Volume 0.14M

Average 0.37M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$62.95M

FY 2025 · Annual

Net Income

-$59.52M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue00000
Cost of Revenue50K000830K
Gross Profit(50K)000(830K)
Gross Margin—————
Research & Development28.12M25.86M32.12M43.8M48.26M
Selling, General & Admin11.65M3.9M4.82M10.59M14.69M
Operating Expenses39.77M29.77M36.93M54.39M62.12M
Depreciation & Amortization50K387K560K662K830K
EBITDA(39.72M)(29.13M)(34.75M)(51.71M)(58.69M)
EBITDA Margin—————
Operating Income(39.82M)(29.77M)(36.93M)(54.39M)(62.95M)
Operating Margin—————
Interest Income0254K1.62M2.01M3.44M
Interest Expense000300K0
Other Income / Expenses48K254K1.62M1.71M3.43M
Income Before Tax(39.77M)(29.51M)(35.31M)(52.67M)(59.52M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(39.77M)(29.51M)(35.31M)(52.67M)(59.52M)
Net Margin—————
EPS (Basic)(21.92)(2.21)(2.65)(3.95)(4.40)
EPS (Diluted)(21.92)(2.21)(2.65)(3.95)(4.40)
Weighted Avg Shares1.81M13.34M13.34M13.34M13.52M
Weighted Avg Shares (Diluted)1.81M13.34M13.34M13.34M13.52M

OKUR Earnings Waterfall · TTM

NASDAQ:OKUR · Revenue to Net Income

Key Ratios

EPS$-4.33
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$58.7M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-4.33, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
SC 13GSC 13G filingOct 7, 2026
4Statement of changes in beneficial ownershipSep 23, 2026
4Statement of changes in beneficial ownershipSep 23, 2026

How much revenue does OKUR generate?

OnKure Therapeutics, Inc. (OKUR) reported $0.00 of revenue in fiscal 2025.

Is OKUR profitable?

OnKure Therapeutics, Inc. (OKUR) reported -$59.52M of net income.